- On Monday there was news that Moderna’s Covid-19 vaccine candidate is generating an immune response in Phase 1 trial subjects.
- We also then saw massive buying push the market cap to now $29 billion. This is NOT a proven company and doesn't have any marketable product YET.
- Some concern has since been expressed by Vaccine experts others on on when company will release full data / research here and that a vaccine is still a long way away.
- Anyway you know the drill here - if you think this is THE Vaccine company then try and find a way into this stock - don't mortgage your house / have a plan and put a small % to work.
- Technically massive uptrend and probably a 2 places to get long - either at the immediate demand zone (66ish) or the 50ish. There is some negative divergence kicking in with the Connor's RSI and so a bigger dip here is possible.